
Russian internet giant Yandex on Friday said it was exploring options, including divestment, for its news aggregation service and its Yandex.Zen content feed and blogging platform.
Nasdaq-listed Yandex, which is facing potential issues in redeeming convertible bonds over a trading suspension of its shares, said the company wanted to focus on developing its other businesses and products.
Zen, with over 20 million users, is an Artificial Intelligence-powered content feed that automatically provides users with video feed based on data, including browsing history, location, and other factors.
Yandex, a multinational corporation founded in 1997 by Russian billionaire Arkady Volozh, primarily develops internet services for Russian and Russian-language users, including search and information services, e-commerce, navigation, mobile applications, and online advertising, in a model similar to Big Tech giant Google. Much like its western rival, Yandex has had run-ins with Russia’s regulator over possible anticompetitive practices involving the company’s use of data.
Yandex has also forayed into the transportation and cab-hailing game, launching Yandex Taxi in a joint venture with Uber in 2019. Uber which had already considered selling its stake in Yandex Taxi, would be speeding up the sale, the company announced, following Russia’s invasion of Ukraine.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas